19 hasil untuk "Mehta, Cyrus"
Menampilkan 1–19 · 0,70 detik · RSS
-
Artikel Jurnal Teks lengkap
Adaptive multiarm multistage clinical trials
Two methods for designing adaptive multiarm multistage (MAMS) clinical trials, originating from conceptually different group sequential frameworks are presented, and their operating characteristics are compared. In both methods pairwise comparisons are made, stage‐by‐stage, between each treatment…
-
Artikel Jurnal Teks lengkap
Graph Based, Adaptive, Multiarm, Multiple Endpoint, Two‐Stage Designs
The graph‐based approach to multiple testing is an intuitive method that enables a study team to represent clearly, through a directed graph, its priorities for hierarchical testing of multiple hypotheses, and for propagating the available type‐1 error from rejected or dropped hypotheses to…
-
Artikel Jurnal Teks lengkap
Testing a Primary and a Secondary Endpoint in a Group Sequential Design
We consider a clinical trial with a primary and a secondary endpoint where the secondary endpoint is tested only if the primary endpoint is significant. The trial uses a group sequential procedure with two stages. The familywise error rate (FWER) of falsely concluding significance on either…
-
Artikel Jurnal Teks lengkap
Optimal promising zone designs
…with a decision rule for increasing the sample size within that zone. Mehta and Pocock (2011) provided some examples of promising zone designs and discussed several procedures for controlling their type‐1 error. They did not, however, address how to choose the promising zone or the corresponding…
-
Artikel Jurnal Teks lengkap
Testing One Primary and Two Secondary Endpoints in a Two‐Stage Group Sequential Trial With Extensions
We study the problem of testing multiple secondary endpoints conditional on a primary endpoint being significant in a two‐stage group sequential procedure, focusing on two secondary endpoints. This extends our previous work with one secondary endpoint. The test for the secondary null hypotheses is…
-
Artikel Jurnal Teks lengkap
The distance of the femoral neurovascular bundle from the hip joint: an intraoperative guide to reduce iatrogenic injury
BACKGROUND: Iatrogenic injury to the femoral neurovascular bundle is not uncommon during primary and revision total hip replacement (THR) and can result in permanent weakness, pain and poor function. Prevention of injury to these structures relies on a sound knowledge of their relationships to the…
-
Artikel Jurnal Teks lengkap
Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial
BACKGROUND: The EXAMINE trial tested the efficacy and safety of alogliptin, an inhibitor of dipeptidyl peptidase 4, compared with placebo in 5380 patients with type 2 diabetes and a recent acute coronary syndrome. Because alogliptin is cleared by the kidney, patients were stratified according to…
-
Artikel Jurnal Teks lengkap
Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial
BACKGROUND: Patients with type 2 diabetes (T2D) may experience frequent body weight changes over time. The prognostic impact of these weight changes (gains or losses) requires further study. AIMS: To study the associations between changes in body weight (intentional or unintentional) with…
-
Artikel Jurnal Teks lengkap
Extensile lateral versus sinus tarsi approach for displaced, intra-articular calcaneal fractures: a meta-analysis
BACKGROUND: Operative management of displaced, intra-articular calcaneal fractures is associated with improved functional outcomes but associated with frequent complications due to poor soft tissue healing. The use of a minimally invasive sinus tarsi approach to the fixation of these fractures may…
-
Artikel Jurnal Teks lengkap
Average Clinician‐Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial
BACKGROUND: Blood pressure (BP) treatment goals in patients with diabetes mellitus and increased cardiovascular risk remain controversial. Our study objective was to determine cardiovascular outcomes according to achieved BPs over the average follow‐up period in the EXAMINE (Examination of…
-
Artikel Jurnal Teks lengkap
Reassessing the Role of Surrogate Endpoints in Drug Development for Heart Failure
With few notable exceptions, drug development for heart failure (HF) has become progressively more challenging and there remain no definitively proven therapies for patients with acute HF or HF with preserved ejection fraction. Inspection of temporal trends suggests an increasing rate of…
-
Artikel Jurnal Teks lengkap
Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome
Alogliptin, a dipeptidyl peptidase‐4 inhibitor, is approved for the treatment of patients with type 2 diabetes (T2DM). EXAMINE was a randomized controlled clinical trial designed to demonstrate the cardiovascular (CV) safety of alogliptin. In the trial, 5380 patients with established T2DM who had a…
-
Artikel Jurnal Teks lengkap
High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
AIMS: We sought to assess the risk of major adverse cardiovascular events (MACE) by utilizing high‐sensitivity C‐reactive protein (hsCRP) level and low‐density lipoprotein cholesterol (LDL‐C) in patients with type 2 diabetes and recent acute coronary syndrome. MATERIALS AND METHODS: Study…
-
Artikel Jurnal Teks lengkap
Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials
IMPORTANCE: Platform trial design allows the introduction of new interventions after the trial is initiated and offers efficiencies to clinical research. However, limited guidance exists on the economic resources required to establish and maintain platform trials. OBJECTIVE: To compare cost (US…
-
Artikel Jurnal Teks lengkap
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial
AIMS: To investigate relationships between glycated haemoglobin (HbA1c) and reported hypoglycaemia and risk of major adverse cardiovascular events (MACE). METHODS: The EXAMINE trial randomized 5380 patients with type 2 diabetes (T2DM) and a recent acute coronary syndrome (ACS) event, in 49…
-
Artikel Jurnal Teks lengkap
REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results
-
Artikel Jurnal Teks lengkap
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
BACKGROUND: Safe and effective treatments are urgently needed for patients with relapsed/refractory acute myeloid leukaemia (AML). We investigated the efficacy and safety of vosaroxin, a first-in-class anticancer quinolone derivative, plus cytarabine in patients with relapsed/refractory AML…
-
Artikel Jurnal Teks lengkap
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations